Abstract:Abstract Necrosis, apoptosis, and fibrosis are characteristics of tissue damage/injuries such as cardiac ischemia and liver damage. In most instances, a loss of blood supply due to death of endothelial cells results, creating a hypoxic environment at the damage sites. In addition, a flux of growth factors and chemokines are induced as a “rescue” signal to recruit exogenous and/or proximal stem cells into proliferation and differentiation. One such soluble factor reported to have both mitogenic and motogenic effect on stem cells for liver and cardiac regeneration is the hepatocyte growth factor (HGF), also known as “scatter factor”. Our lab has previously demonstrated that administration of HGF in vivo following human hematopoietic stem cell transplantation into an immune deficient mouse model of liver injury greatly enhances recruitment of human stem cells to sites of liver damage (Wang et al, Blood 2003). In the current studies, we addressed the role of HGF in promoting human bone marrow-derived mesenchymal stem cells (MSC) to sites of tissue damage such as liver or cardiac ischemia. In addition to exploiting the beneficial effect of HGF, we also evaluated the possible additive effect of hypoxia in stem cell regeneration based on the following hypothesis - that exposure of MSC to hypoxic conditions prior to transplantation will enhance the levels of c-met and amplify the signaling cascades downstream of HGF/c-met. To answer the question of whether MSCs have increased motility in hypoxic conditions, human bone marrow derived MSC were cultured in hypoxic (2 to 3% oxygen) vs. normoxic conditions (20–21% O2) in the presence or absence of 25ng/ml HGF, and scratch tests were performed to assess the scattering potential of MSC. There was an increase in total c-met protein, by immunohistochemical analysis, and increased migration of MSC under hypoxic conditions with HGF, as compared to normoxic conditions with HGF. Protein studies were designed to measure c-met induction/stabilization and downstream signals following ligand binding. By immunoprecipitation followed by immunoblotting with specific phosphorylation antibodies, we showed that hypoxic conditions + HGF stimulation induced a higher level of total cellular phosphotyrosine activity in MSC. Downstream of HGF/c-met, we observed an amplification of AKT phosphorylation when comparing HGF stimulation under normoxic vs. hypoxic conditions. In contrast, MAPK phosphorylation was moderately, but not significantly, different between hypoxic vs. normoxic conditions. Our data from these functional and molecular studies suggest that pre-treatment of MSC under hypoxic conditions might not only increase c-met to enhance HGF-mediated chemotactic recruitment to sites of tissue damage but may also enhance the survival of these stem cells upon arrival at the damaged site, through increasing the levels of phosphorylation of the pro-survival protein AKT.

ERK1/2 and Akt Phosphorylation Were Essential for MGF E Peptide Regulating Cell Morphology and Mobility but Not Proangiogenic Capacity of BMSCs under Severe Hypoxia.

MGF E peptide pretreatment improves the proliferation and osteogenic differentiation of BMSCs via MEK-ERK1/2 and PI3K-Akt pathway under severe hypoxia.

Mechano Growth Factor E Peptide Regulates Migration and Differentiation of Bone Marrow Mesenchymal Stem Cells.

Hypoxia Inhibits the Spontaneous Calcification of Bone Marrow‐derived Mesenchymal Stem Cells

MGF E Peptide Improves Anterior Cruciate Ligament Repair by Inhibiting Hypoxia‐induced Cell Apoptosis and Accelerating Angiogenesis

Pretreatment with mechano growth factor E peptide attenuates osteoarthritis through improving cell proliferation and extracellular matrix synthesis in chondrocytes under severe hypoxia

Erythropoietin signal pathway is upregulated in mesenchymal stem cell during hypoxia

A synthetic mechano-growth factor E peptide promotes rat tenocyte migration by lessening cell stiffness and increasing F-actin formation via the FAK-ERK1/2 signaling pathway.

Effects of Mesenchymal Stem Cells on Matrix Metalloproteinase Synthesis in Cardiac Fibroblasts

Mechano Growth Factor E Peptide Promotes Rat Bone Marrow-Derived Mesenchymal Stem Cell Migration Through CXCR4-ERK1/2.

Prolyl Hydroxylase Inhibitor Dimethyloxalylglycine Enhances Mesenchymal Stem Cell Survival

Heregulin Protects Mesenchymal Stem Cells from Serum Deprivation and Hypoxia-Induced Apoptosis

BONE MARROW MESENCHYMAL STEM CELL MIGRATION DEPENDS IN PART ON KV21 CHANNEL ACTIVITY

Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration Via PI3K/Akt and ERK1/2 Pathways

Mechano-Growth Factor E Peptide Inhibits the Differentiation and Mineralization of Osteoblasts

Hypoxia Induces Osteogenic/Angiogenic Responses of Bone Marrow-Derived Mesenchymal Stromal Cells Seeded on Bone-Derived Scaffolds Via Erk1/2 and P38 Pathways

Angiogenic/Osteogenic Response of Bmmscs on Bone-Derived Scaffold: Effect of Hypoxia and Role of Pi3k/Akt-Mediated Vegf-Vegfr Pathway

Working Toward Better Tissue Repair Therapies: Exposure of MSC to Hypoxic Conditions In Vitro Increases Levels of the Hepatocyte Growth Factor Receptor c-met, Improves Motility, and Induces Phosphorylation of the Pro-Survival Protein AKT.

TGFβ1 Improves the Proliferation of Decellularized and Aligned Skeletal Muscle in Extracellular Matrix Hydrogels by M6a Modification-Mediated Integrin Through Inducing ERK Phosphorylation

Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells

Mechano-growth Factor Induces Migration of Rat Mesenchymal Stem Cells by Altering Its Mechanical Properties and Activating ERK Pathway